Literature DB >> 9420260

Genetic determinants of Rous sarcoma virus particle size.

N K Krishna1, S Campbell, V M Vogt, J W Wills.   

Abstract

The Gag proteins of retroviruses are the only viral products required for the release of membrane-enclosed particles by budding from the host cell. Particles released when these proteins are expressed alone are identical to authentic virions in their rates of budding, proteolytic processing, and core morphology, as well as density and size. We have previously mapped three very small, modular regions of the Rous sarcoma virus (RSV) Gag protein that are necessary for budding. These assembly domains constitute only 20% of RSV Gag, and alterations within them block or severely impair particle formation. Regions outside of these domains can be deleted without any effect on the density of the particles that are released. However, since density and size are independent parameters for retroviral particles, we employed rate-zonal gradients and electron microscopy in an exhaustive study of mutants lacking the various dispensable segments of Gag to determine which regions would be required to constrain or define the particle dimensions. The only sequence found to be absolutely critical for determining particle size was that of the initial capsid cleavage product, CA-SP, which contains all of the CA sequence plus the spacer peptides located between CA and NC. Some regions of CA-SP appear to be more important than others. In particular, the major homology region does not contribute to defining particle size. Further evidence for interactions among CA-SP domains was obtained from genetic complementation experiments using mutant deltaNC, which lacks the RNA interaction domains in the NC sequence but retains a complete CA-SP sequence. This mutant produces low-density particles heterogeneous in size. It was rescued into particles of normal size and density, but only when the complementing Gag molecules contained the complete CA-SP sequence. We conclude that CA-SP functions during budding in a manner that is independent of the other assembly domains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420260      PMCID: PMC109409     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity.

Authors:  T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

2.  WW domains and retrovirus budding.

Authors:  L Garnier; J W Wills; M F Verderame; M Sudol
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

3.  Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses.

Authors:  R B Pepinsky; I A Papayannopoulos; E P Chow; N K Krishna; R C Craven; V M Vogt
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

4.  An assembly domain of the Rous sarcoma virus Gag protein required late in budding.

Authors:  J W Wills; C E Cameron; C B Wilson; Y Xiang; R P Bennett; J Leis
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein.

Authors:  R C Craven; A E Leure-duPree; R A Weldon; J W Wills
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein.

Authors:  L J Parent; C B Wilson; M D Resh; J W Wills
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.

Authors:  R P Bennett; T D Nelle; J W Wills
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.

Authors:  S Campbell; V M Vogt
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.

Authors:  L J Parent; R P Bennett; R C Craven; T D Nelle; N K Krishna; J B Bowzard; C B Wilson; B A Puffer; R C Montelaro; J W Wills
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.

Authors:  H G Kräusslich; M Fäcke; A M Heuser; J Konvalinka; H Zentgraf
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  40 in total

1.  PR domain of rous sarcoma virus Gag causes an assembly/budding defect in insect cells.

Authors:  M C Johnson; H M Scobie; V M Vogt
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy.

Authors:  V M Vogt; M N Simon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.

Authors:  J B Bowzard; J W Wills; R C Craven
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.

Authors:  N K Krishna; J W Wills
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Nucleic acid-independent retrovirus assembly can be driven by dimerization.

Authors:  Marc C Johnson; Heather M Scobie; Yu May Ma; Volker M Vogt
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.

Authors:  S M Joshi; V M Vogt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  The TY3 Gag3 spacer controls intracellular condensation and uncoating.

Authors:  Kristina Clemens; Liza Larsen; Min Zhang; Yurii Kuznetsov; Virginia Bilanchone; Arlo Randall; Adam Harned; Rhonda Dasilva; Kunio Nagashima; Alexander McPherson; Pierre Baldi; Suzanne Sandmeyer
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

9.  Protein delivery using engineered virus-like particles.

Authors:  Stanislaw J Kaczmarczyk; Kalavathy Sitaraman; Howard A Young; Stephen H Hughes; Deb K Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

10.  Intermolecular interactions between retroviral Gag proteins in the nucleus.

Authors:  Scott P Kenney; Timothy L Lochmann; Cullen L Schmid; Leslie J Parent
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.